Table: Kyowa Kirin -2021 parent results
Feb 7 (Reuters)-
Kyowa Kirin Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2021 Dec 31, 2020 Dec 31, 2022 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 237.59 252.93
(-6.1 pct) (+2.7 pct)
Operating 24.80 48.67
(-49.0 pct) (-2.7 pct)
Recurring 35.23 49.56
(-28.9 pct) (-32.4 pct)
Net 66.37 31.25
(+112.4 pct) (-65.8 pct)
EPS 123.52 yen 58.18 yen
EPS Diluted 123.47 yen 58.15 yen
Ann Div 46.00 yen 44.00 yen 48.00 yen
-Q2 Div 23.00 yen 22.00 yen 24.00 yen
-Q4 Div 23.00 yen 22.00 yen 24.00 yen
NOTE - Kyowa Kirin Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4151.T
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia